Genomics BioSci & Tech. Co.,Ltd. (TPE:4195)
Taiwan · Delayed Price · Currency is TWD 15.70
+0.05 (0.32%)
At close: Jun 18, 2026
Genomics BioSci & Tech. Market Cap
Genomics BioSci & Tech. has a market cap or net worth of 1.14 billion as of June 18, 2026. Its market cap has decreased by -15.59% in one year.
Market Cap
1.14B
Enterprise Value
1.72B
Revenue
738.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.70
Market Cap Chart
Since December 16, 2013, Genomics BioSci & Tech.'s market cap has decreased from 1.58B to 1.14B, a decrease of -28.06%. That is a compound annual growth rate of -2.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.14B | -38.91% |
| Dec 31, 2025 | 1.86B | 33.85% |
| Dec 31, 2024 | 1.39B | -7.69% |
| Dec 29, 2023 | 1.51B | 19.84% |
| Dec 30, 2022 | 1.26B | 11.67% |
| Dec 30, 2021 | 1.13B | 0.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 21.65B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.53B |
| Tripartite Therapeutics | 8.11B |
| Intelligene | 6.61B |
| Uwell Biopharma | 6.57B |
| Obigen Pharma | 3.89B |
| Pet Pharm Biotech | 2.90B |
| BIONET Therapeutics | 2.58B |